x

Blog

Updates from the 2016 Cancer Survivorship Symposium

Guest post by Stacey Tinianov and Dr. Nimmi Kapoor Survivorship Symposium: A Review On Friday, January 15th, a diverse group of over 800 attendees met in San Francisco for the inaugural two-day Survivorship Symposium, jointly sponsored by the American Society of Clinical Oncology (ASCO), the American Academy of Family Physicians (AAFP) and the American College […]

Read more ›
The Metastatic Breast Cancer Project – An Update

Guest Post by Corrie Painter, Ph.D The Metastatic Breast Cancer Project is a nationwide patient-driven research project launched at the Broad Institute of MIT and Harvard & Dana-Farber Cancer Institute in October of 2015. Along with our advocacy partners (the Metastatic Breast Cancer Network, the Metastatic Breast Cancer Alliance, Living Beyond Breast Cancer, Young Survivor Coalition, […]

Read more ›
Screening Guidelines – Always Changing!
On: Jan 18, 2016
By: Alicia

On January 18th, 2016, the #BCSM community will discuss the ever changing nature of cancer screenings. Early in January, the U.S. Preventive Services Task Force announced new guidelines stating that mammograms before age 50 were no longer essential.  You can read the press releases and latest news here: USPSTF Task Force Recommendations Dr. Deanna Attai, one […]

Read more ›
Quality Of Life Research – DIVAS Study

Guest Post by Kristen D. Rosen MPD, PhD (Candidate) DIVAS Study: Help us evaluate a mindfulness app for women with breast cancer We are asking for your help to evaluate a mindfulness app and learn more about using mobile technology to deliver health interventions to women with breast cancer. Mindfulness training may help people with […]

Read more ›
Male Breast Cancer
On: Oct 18, 2015
By: bcsmadmin

19 October 2015 This week’s chat will focus on male breast cancer. Approximately 1 in 1000 men will be affected annually in the US, accounting for approximately 2350 cases per year. Approximately 440 men will die due to metastatic breast cancer. Male breast cancer is often diagnosed in later stages compared to women for several […]

Read more ›